Molecular Partners AG ADRMOLN
Price$3.95Intrinsic value$5.4638% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $5.46median of 2 methodsbased on filings through 30 Jun 2025
Market Price $3.95Price as of 30 Sep 2026
Margin of Safety +38.1%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 9.1%/yr (balance of the path).8.3% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 69.0%Yr 78.8%Yr 88.6%Yr 98.5%Yr 108.3%
9.1% → 8.3%
Years 11–20: glide to long-run rate
Per-year rates
Yr 117.8%Yr 127.2%Yr 136.7%Yr 146.2%Yr 155.6%Yr 165.1%Yr 174.6%Yr 184.1%Yr 193.5%Yr 203.0%
8.3% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 8.5%
Volatility vs market (adjusted beta)0.79

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetMolecular Partners AG ADRMOLNHealth Care
Valuation
P/E—
P/S32.5×
P/B2.0×
EV / Revenue16.6×
EV / EBITDA-0.8×
Profitability
Gross margin0.0%
Operating margin-1,336.3%
Net margin-1,417.4%
FCF margin-1,197.7%
Returns
ROE-76.6%
ROA-60.2%
ROIC—
Growth
Revenue growth (YoY)0.0%
5-yr fwd EPS growth8.3%
Financial strength
Debt / Equity0.04×
Current ratio8.79×
Altman Z-Score—
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.